GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocugen Inc (MEX:OCGN) » Definitions » Price-to-Free-Cash-Flow

Ocugen (MEX:OCGN) Price-to-Free-Cash-Flow : N/A (As of May. 25, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Ocugen Price-to-Free-Cash-Flow?

As of today (2025-05-25), Ocugen's share price is MXN16.00. Ocugen's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 was MXN-3.68. Hence, Ocugen's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Ocugen's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Ocugen's highest Price-to-Free-Cash-Flow Ratio was 2.38. The lowest was 0.87. And the median was 1.50.

MEX:OCGN's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 29.42
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Ocugen's Free Cash Flow per Share for the three months ended in Mar. 2025 was MXN-1.36. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was MXN-3.68.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 12.50% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 18.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 60.20% per year.

During the past 13 years, Ocugen's highest 3-Year average Free Cash Flow per Share Growth Rate was 87.00% per year. The lowest was -35.80% per year. And the median was 39.40% per year.


Ocugen Price-to-Free-Cash-Flow Historical Data

The historical data trend for Ocugen's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocugen Price-to-Free-Cash-Flow Chart

Ocugen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ocugen Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ocugen's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Ocugen's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocugen's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocugen's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ocugen's Price-to-Free-Cash-Flow falls into.


;
;

Ocugen Price-to-Free-Cash-Flow Calculation

Ocugen's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=16.00/-3.677
=N/A

Ocugen's Share Price of today is MXN16.00.
Ocugen's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-3.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Ocugen  (MEX:OCGN) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Ocugen Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Ocugen's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Ocugen Business Description

Traded in Other Exchanges
Address
11 Great Valley Parkway, Malvern, PA, USA, 19355
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").